Skip to search.
 TSX Up 0.16% TSX Ventures Down 0.30%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
4.45 Down 0.25(5.32%) 4:00PM EDT
|After Hours : 4.45 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price
Prev Close:4.70
Open:4.67
Bid:4.44 x 15600
Ask:4.45 x 13800
1y Target Est:6.33
Beta:1.95839
Next Earnings Date: 7-Nov-16BCRX Earnings announcement
Day's Range:4.40 - 4.70
52wk Range:1.63 - 12.88
Volume:707,123
Avg Vol (3m):964,064
Market Cap:327.97M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BCRXDown 5.32%327.97M
GSKDown 1.76%102.59B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.03
Quarterly EPS Est (Sep-16) :-0.25
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback